Paolo Nencini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Paolo Nencini has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Aldo Badiani
Department of Psychology, University of Sussex, UK
10 shared publications Lorenza De Carolis
Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy
5 shared publicationsMichele S. Milella
Sapienza University of Rome, Italy
5 shared publications- Chiara Schepisi
Affiliation National Institute for Health, Migration and Poverty (INMP), Rome, Italy
4 shared publications Letizia Antonilli
Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy
4 shared publicationsSabina Fraioli
Institute of Medical Pharmacology, University of Rome "La Sapienza," P.le A. Moro 5 00185, Rome, Italy
4 shared publications
Latest Publications
- 7 June 2014
- Published by Springer Nature
- p. 1-5
Khat
- 20 March 2014
- Published by Springer Nature in Psychopharmacology
- Vol. 231 (19) , 3889-3897
Differences in the structure of drinking, cart expression and dopamine turnover between polydipsic and non polydipsic rats in the quinpirole model of psychotic polydipsia
Dopaminergic D2/D3 agonist quinpirole (QNP) elicits nonregulatory drinking in rats, a model of psychotic polydipsia. Why only a fraction of QNP-treated rats responds to the treatment becoming polydipsic is still unclear.
- 20 March 2014
- Published by Springer Nature in Psychopharmacology
- Vol. 231 (19) , 3889-3897
Differences in the structure of drinking, cart expression and dopamine turnover between polydipsic and non polydipsic rats in the quinpirole model of psychotic polydipsia
Dopaminergic D2/D3 agonist quinpirole (QNP) elicits nonregulatory drinking in rats, a model of psychotic polydipsia. Why only a fraction of QNP-treated rats responds to the treatment becoming polydipsic is still unclear.
- 1 December 2013
- Published by Elsevier in Neuropharmacology
- Vol. 75, 391-398
In vitro morphine metabolism by rat microglia
- 1 December 2013
- Published by Elsevier in Neuropharmacology
- Vol. 75, 391-398
In vitro morphine metabolism by rat microglia
- 1 May 2013
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 36 (3) , 100-101
Polydrug Abuse by Intravenous Use of Heroin and Tropicamide-Containing Eyedrops
BACKGROUND: Drug abuse is rarely limited to a single substance; polydrug use is the norm rather than the exception. In many cases, the misuse of potentially psychoactive substances can lead to serious intoxications and results in addictive behavior. CASE DESCRIPTION: A 22-year-old heroin-addicted woman presented in our clinic reporting a 2-year history of intravenous injection of an eyedrop solution containing 1% tropicamide, an antimuscarinic agent. She reported injecting tropicamide because it attenuated symptoms and signs of opiate withdrawal and it also has hallucinogenic and euphorigenic effects. Despite the large amounts (up to 1.5 g), the rapidity of injection, and the long-term use, tropicamide was relatively well tolerated, without life-threatening consequences.An outpatient detoxification program was performed without any sign or symptom caused by discontinuing tropicamide. CONCLUSIONS: The present case claims a role for pharmacological interactions, in addition to rewarding effects, in influencing drug association in polyabuse pattern.Moreover, this case underlines the need for physicians to be aware of the potential emergence of tropicamide as a drug of misuse, to prevent further harm. Copyright © 2013 by Lippincott Williams & Wilkins
- 1 May 2013
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 36 (3) , 100-101
Polydrug Abuse by Intravenous Use of Heroin and Tropicamide-Containing Eyedrops
BACKGROUND: Drug abuse is rarely limited to a single substance; polydrug use is the norm rather than the exception. In many cases, the misuse of potentially psychoactive substances can lead to serious intoxications and results in addictive behavior. CASE DESCRIPTION: A 22-year-old heroin-addicted woman presented in our clinic reporting a 2-year history of intravenous injection of an eyedrop solution containing 1% tropicamide, an antimuscarinic agent. She reported injecting tropicamide because it attenuated symptoms and signs of opiate withdrawal and it also has hallucinogenic and euphorigenic effects. Despite the large amounts (up to 1.5 g), the rapidity of injection, and the long-term use, tropicamide was relatively well tolerated, without life-threatening consequences.An outpatient detoxification program was performed without any sign or symptom caused by discontinuing tropicamide. CONCLUSIONS: The present case claims a role for pharmacological interactions, in addition to rewarding effects, in influencing drug association in polyabuse pattern.Moreover, this case underlines the need for physicians to be aware of the potential emergence of tropicamide as a drug of misuse, to prevent further harm. Copyright © 2013 by Lippincott Williams & Wilkins
- 16 December 2012
- Published by Springer Nature in Psychopharmacology
- Vol. 227 (1) , 55-66
Effects of the 5HT2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behavior
In rats, quinpirole, a dopaminergic D2/D3 receptor agonist, elicits both hyperdipsia and water “contrafreeloading” (CFL), a putative model of compulsivity. The role of D3 receptors in this effect remains unclear. Clomipramine (CIM) was found to contrast both hyperdipsia and CFL, but the role of serotonin in this effect requires further investigation.
- 16 December 2012
- Published by Springer Nature in Psychopharmacology
- Vol. 227 (1) , 55-66
Effects of the 5HT2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behavior
In rats, quinpirole, a dopaminergic D2/D3 receptor agonist, elicits both hyperdipsia and water “contrafreeloading” (CFL), a putative model of compulsivity. The role of D3 receptors in this effect remains unclear. Clomipramine (CIM) was found to contrast both hyperdipsia and CFL, but the role of serotonin in this effect requires further investigation.
- 10 June 2011
- Published by Springer Nature in Psychopharmacology
- Vol. 218 (4) , 749-759
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior
Repeated administrations of the D2/D3 agonist quinpirole (QNP) to rats elicit an antieconomical pattern of drinking called “contrafreeloading” (CFL), a putative model of compulsive-like behavior.
- 10 June 2011
- Published by Springer Nature in Psychopharmacology
- Vol. 218 (4) , 749-759
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior
Repeated administrations of the D2/D3 agonist quinpirole (QNP) to rats elicit an antieconomical pattern of drinking called “contrafreeloading” (CFL), a putative model of compulsive-like behavior.
- 11 February 2011
- Published by Springer Nature in Psychopharmacology
- Vol. 215 (4) , 749-760
The role of setting in the oral self-administration of alcohol in the rat
Rationale We have previously found that rats that were kept at all times in the self-administration (SA) chambers (resident group) self-administered more heroin than rats that were transferred to the SA chambers immediately before testing (Non-Resident group). Alcohol resembles heroin in its ability to produce, at recreational doses, mood elevation, euphoria, drowsiness, and sedation. Furthermore, alcohol presents some similarities with the mechanisms of action of heroin at the levels of the mesostriatal circuitry. Therefore, we predicted that, as for heroin, alcohol intake would be greater in the Resident than in the Non-Resident group. Materials and methods In Experiment 1, oral self-administration of ethanol and wine solutions (2.5%, 5%, and 10%, v/v) was assessed in Resident and Non-Resident rats using both one-bottle (three sessions) and two-bottle (seven sessions) tests. In addition, we also assessed the intake of water (Experiment 2) and of 0.04% saccharin–0.003% quinine solution (Experiment 3). Results During the one-bottle sessions, alcohol intake of Resident rats was up to two times that of Non-Resident rats. During the two-bottle sessions, Resident rats drank two times more 5% alcohol than water, whereas Non-Resident rats took equal amount of the two fluids. The average daily intake of pure ethanol for Resident rats given access to 5% solutions was 0.71 ± 0.076 vs. 0.46 ± 0.078 g/kg for Non-Resident rats. No group differences in the intake of water and of saccharin–quinine solution were found. Conclusion The present report demonstrates at a preclinical level the importance of setting for alcohol self-administration.
- 11 February 2011
- Published by Springer Nature in Psychopharmacology
- Vol. 215 (4) , 749-760
The role of setting in the oral self-administration of alcohol in the rat
Rationale We have previously found that rats that were kept at all times in the self-administration (SA) chambers (resident group) self-administered more heroin than rats that were transferred to the SA chambers immediately before testing (Non-Resident group). Alcohol resembles heroin in its ability to produce, at recreational doses, mood elevation, euphoria, drowsiness, and sedation. Furthermore, alcohol presents some similarities with the mechanisms of action of heroin at the levels of the mesostriatal circuitry. Therefore, we predicted that, as for heroin, alcohol intake would be greater in the Resident than in the Non-Resident group. Materials and methods In Experiment 1, oral self-administration of ethanol and wine solutions (2.5%, 5%, and 10%, v/v) was assessed in Resident and Non-Resident rats using both one-bottle (three sessions) and two-bottle (seven sessions) tests. In addition, we also assessed the intake of water (Experiment 2) and of 0.04% saccharin–0.003% quinine solution (Experiment 3). Results During the one-bottle sessions, alcohol intake of Resident rats was up to two times that of Non-Resident rats. During the two-bottle sessions, Resident rats drank two times more 5% alcohol than water, whereas Non-Resident rats took equal amount of the two fluids. The average daily intake of pure ethanol for Resident rats given access to 5% solutions was 0.71 ± 0.076 vs. 0.46 ± 0.078 g/kg for Non-Resident rats. No group differences in the intake of water and of saccharin–quinine solution were found. Conclusion The present report demonstrates at a preclinical level the importance of setting for alcohol self-administration.
- 10 July 2010
- Published by Springer Nature in Psychopharmacology
- Vol. 212 (1) , 105-115
The effects of clozapine on quinpirole-induced non-regulatory drinking and prepulse inhibition disruption in rats
The biological underpinnings of schizophrenic polydipsia are poorly understood.
- 10 July 2010
- Published by Springer Nature in Psychopharmacology
- Vol. 212 (1) , 105-115
The effects of clozapine on quinpirole-induced non-regulatory drinking and prepulse inhibition disruption in rats
The biological underpinnings of schizophrenic polydipsia are poorly understood.
- 16 June 2010
- Published by Springer Nature in Psychopharmacology
- Vol. 211 (3) , 355-366
Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia
Repeated administration of the dopamine D2/D3 agonist quinpirole (QNP) progressively increases non-regulatory water intake. This effect may model psychotic polydipsia, a potentially fatal but poorly understood condition.
- 16 June 2010
- Published by Springer Nature in Psychopharmacology
- Vol. 211 (3) , 355-366
Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia
Repeated administration of the dopamine D2/D3 agonist quinpirole (QNP) progressively increases non-regulatory water intake. This effect may model psychotic polydipsia, a potentially fatal but poorly understood condition.
- 13 April 2010
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 45 (13) , 2130-2151
Psychobiology of Drug-Induced Religious Experience: From the Brain “Locus of Religion” to Cognitive Unbinding
The recent interest in the psychopharmacological underpinnings of religious experiences has led to both the laboratory characterizations of drug-induced mystical events and psychobiological models of religious experiences rooted in evolution and fitness. Our examination of this literature suggests that these theories may be congruent only within more modern religious and cultural settings and are not generalizable to all historical beliefs, as would be expected from an evolutionarily conserved biological mechanism. The strong influence of culture on the subjective effects of drugs as well as religious thoughts argues against the concept of a common pathway in the brain uniquely responsible for these experiences. Rather, the role of personal beliefs, expectations and experiences may interject bias into the interpretation of psychoactive drug action as a reflection of biologically based religious thought. Thus, psychobiological research proposing specific brain mechanisms should consider anthropological and historical data to address alternative explanations to the “fitness” of religious thought. A psychobiological model of the religious experience based on the concept of cognitive unbinding seems to accommodate these data better than that of a specific brain locus of religion. L’intérêt tout récent pour les fondements psychopharmacologiques des pratiques religieuses a donné lieu aux caractérisations en laboratoire d’événements mystiques d’origine médicamenteuse et à des modèles psychobiologiques de pratiques religieuses trouvant leur origine dans l’évolution et le conditionnement physique. Il ressort de notre examen de cette documentation que ces théories entrent uniquement dans la logique de cadres religieux et culturels plus modernes et qu’une généralisation de ceux-ci à toutes les croyances historiques est impossible, bien que ce soit ce que l’on attende d’un mécanisme biologique préservé de manière évolutive. L’influence culturelle conséquente sur les effets subjectifs des médicaments et les réflexions religieuses tendent à réfuter le concept d’une voie commune dans le cerveau qui serait responsable à elle seule de ces pratiques. Au lieu de cela, le rôle des croyances, des attentes et des expériences personnelles sont susceptibles d’interposer un parti pris dans l’interprétation de l’activité médicamenteuse psychoactive comme le reflet de la pensée religieuse fondée sur des références biologiques. Aussi, il revient aux recherches psychobiologiques suggérant le recours à des mécanismes cérébraux spécifiques de se pencher sur les données anthropologiques et historiques pour aborder les autres explications du «conditionnement physique» de la pensée religieuse. Un modèle psychobiologique de la pratique religieuse reposant sur le concept de libération cognitive semble s’adapter davantage à ces données qu’à celles d’un locus cérébral particulier. El recién interés por los fundamentos farmacológicos de las experiencias religiosas ha llevado tanto a la caracterización experimental de los eventos místicos inducidos por los fármacos, como al desarrollo de unos modelos psicobiológicos de las experiencias religiosas que tienen su base en la evolución y en la adaptación. El examen de esta literatura sugiere que estas teorías son congruentes sólo en contextos religiosos y culturales modernos y no se pueden extender a todas las creencias religiosas históricamente conocidas, como podría esperarse a partir de un mecanismo biológico evolutivamente conservado. La fuerte influencia de la cultura sobre los efectos subjetivos de los fármacos y sobre el pensamiento religioso niegan el concepto de una vía común en el cerebro, como única responsable de estas experiencias. Más bien, el papel de las creencias personales, de las expectativas y de las experiencias puede interferir con lainterpretación de la acción de los fármacos psicoactivos que refleja el pensamiento religioso basado en la biologia. De esta manera, la investigación psicofarmacológica, proponiendo mecanismos cerebrales específicos debería tomar en cuenta datos antopológicos e históricos para proponer hipótesis alternativas acerca de la capacidad adptativa, en sentido darwiniano, del pensamiento religioso. En este sentido, la hipótesis de que la experiencia religiosa podría consistir en un caso especial de “disociación cognitiva” toma un fuerte releve psicobiológico. Il recente interesse nei fondamenti farmacologico delle esperienze religiose ha condotto sia alla caratterizzazione sperimentale degli eventi mistici indotti dai farmaci sia a allo sviluppo di modelli psicobiologici della esperienza religiosa fondati sull’evoluzione e sull’adattamento. L’esame di questa letteratura suggerisce che queste teorie sono congruenti solo con i contesti religiosi e culturali moderni e non sono generalizzabili a tutti le credenze religiose storicamente attestate, come ci si aspetterebbe da un meccanismo biologico evolutivamente conservato. La robusta influenza della cultura sugli effetti soggettivi dei farmaci e sul pensiero religioso depongono contro il concetto di una via comune nel cervello come unico responsabile di queste esperienze. Piuttosto, il ruolo dei convincimenti personali, delle aspettative e delle esperienze può interferire con l’interpretazione dell’azione dei farmaci psicoattivi che riflette il pensiero religioso basato sulla biologia. Così, la ricerca psicofarmacologica proponendo meccanismi cerebrali specifici dovrebbe considerare dati antropologici e storici per proporre ipotesi alternative riguardo la capacità adattativa, in senso darwiniano, del pensiero religioso. In questo contesto, l’ipotesi che l’esperienza religiosa consista in un caso particolare di “dissociazione cognitiva” assume una robusta valenza psicobiologica.
- 13 April 2010
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 45 (13) , 2130-2151
Psychobiology of Drug-Induced Religious Experience: From the Brain “Locus of Religion” to Cognitive Unbinding
The recent interest in the psychopharmacological underpinnings of religious experiences has led to both the laboratory characterizations of drug-induced mystical events and psychobiological models of religious experiences rooted in evolution and fitness. Our examination of this literature suggests that these theories may be congruent only within more modern religious and cultural settings and are not generalizable to all historical beliefs, as would be expected from an evolutionarily conserved biological mechanism. The strong influence of culture on the subjective effects of drugs as well as religious thoughts argues against the concept of a common pathway in the brain uniquely responsible for these experiences. Rather, the role of personal beliefs, expectations and experiences may interject bias into the interpretation of psychoactive drug action as a reflection of biologically based religious thought. Thus, psychobiological research proposing specific brain mechanisms should consider anthropological and historical data to address alternative explanations to the “fitness” of religious thought. A psychobiological model of the religious experience based on the concept of cognitive unbinding seems to accommodate these data better than that of a specific brain locus of religion. L’intérêt tout récent pour les fondements psychopharmacologiques des pratiques religieuses a donné lieu aux caractérisations en laboratoire d’événements mystiques d’origine médicamenteuse et à des modèles psychobiologiques de pratiques religieuses trouvant leur origine dans l’évolution et le conditionnement physique. Il ressort de notre examen de cette documentation que ces théories entrent uniquement dans la logique de cadres religieux et culturels plus modernes et qu’une généralisation de ceux-ci à toutes les croyances historiques est impossible, bien que ce soit ce que l’on attende d’un mécanisme biologique préservé de manière évolutive. L’influence culturelle conséquente sur les effets subjectifs des médicaments et les réflexions religieuses tendent à réfuter le concept d’une voie commune dans le cerveau qui serait responsable à elle seule de ces pratiques. Au lieu de cela, le rôle des croyances, des attentes et des expériences personnelles sont susceptibles d’interposer un parti pris dans l’interprétation de l’activité médicamenteuse psychoactive comme le reflet de la pensée religieuse fondée sur des références biologiques. Aussi, il revient aux recherches psychobiologiques suggérant le recours à des mécanismes cérébraux spécifiques de se pencher sur les données anthropologiques et historiques pour aborder les autres explications du «conditionnement physique» de la pensée religieuse. Un modèle psychobiologique de la pratique religieuse reposant sur le concept de libération cognitive semble s’adapter davantage à ces données qu’à celles d’un locus cérébral particulier. El recién interés por los fundamentos farmacológicos de las experiencias religiosas ha llevado tanto a la caracterización experimental de los eventos místicos inducidos por los fármacos, como al desarrollo de unos modelos psicobiológicos de las experiencias religiosas que tienen su base en la evolución y en la adaptación. El examen de esta literatura sugiere que estas teorías son congruentes sólo en contextos religiosos y culturales modernos y no se pueden extender a todas las creencias religiosas históricamente conocidas, como podría esperarse a partir de un mecanismo biológico evolutivamente conservado. La fuerte influencia de la cultura sobre los efectos subjetivos de los fármacos y sobre el pensamiento religioso niegan el concepto de una vía común en el cerebro, como única responsable de estas experiencias. Más bien, el papel de las creencias personales, de las expectativas y de las experiencias puede interferir con lainterpretación de la acción de los fármacos psicoactivos que refleja el pensamiento religioso basado en la biologia. De esta manera, la investigación psicofarmacológica, proponiendo mecanismos cerebrales específicos debería tomar en cuenta datos antopológicos e históricos para proponer hipótesis alternativas acerca de la capacidad adptativa, en sentido darwiniano, del pensamiento religioso. En este sentido, la hipótesis de que la experiencia religiosa podría consistir en un caso especial de “disociación cognitiva” toma un fuerte releve psicobiológico. Il recente interesse nei fondamenti farmacologico delle esperienze religiose ha condotto sia alla caratterizzazione sperimentale degli eventi mistici indotti dai farmaci sia a allo sviluppo di modelli psicobiologici della esperienza religiosa fondati sull’evoluzione e sull’adattamento. L’esame di questa letteratura suggerisce che queste teorie sono congruenti solo con i contesti religiosi e culturali moderni e non sono generalizzabili a tutti le credenze religiose storicamente attestate, come ci si aspetterebbe da un meccanismo biologico evolutivamente conservato. La robusta influenza della cultura sugli effetti soggettivi dei farmaci e sul pensiero religioso depongono contro il concetto di una via comune nel cervello come unico responsabile di queste esperienze. Piuttosto, il ruolo dei convincimenti personali, delle aspettative e delle esperienze può interferire con l’interpretazione dell’azione dei farmaci psicoattivi che riflette il pensiero religioso basato sulla biologia. Così, la ricerca psicofarmacologica proponendo meccanismi cerebrali specifici dovrebbe considerare dati antropologici e storici per proporre ipotesi alternative riguardo la capacità adattativa, in senso darwiniano, del pensiero religioso. In questo contesto, l’ipotesi che l’esperienza religiosa consista in un caso particolare di “dissociazione cognitiva” assume una robusta valenza psicobiologica.